Lipidomics enables the systematic analysis of the composition, functions, and metabolic networks of lipid molecules in organisms. Its holistic analytical characteristics are highly consistent with the “multi-component, multi-target, and holistic regulation” mode of traditional Chinese medicine (TCM), providing key technical support for elucidating mechanisms of TCM in treating liver diseases. This article systematically reviews the research achievements in the field of lipidomics applied to TCM for liver disease treatment over the past five years. It focuses on analyzing the regulatory effects of TCM on various liver disease-related metabolic pathways and key targets, organizes the lipid regulation mechanisms of different TCM therapeutic approaches, and summarizes the application value of lipidomics in analyzing the efficacy-related substances of TCM, validating the processing of Chinese medicinal materials, and elucidating the mechanisms of TCM formulation compatibility. The study aims to provide theoretical references and practical insights for enhancing research on mechanism of TCM in treating liver diseases through lipidomics, promoting clinical precision diagnosis and treatment, and advancing modernization of TCM theory.
Key words
lipidomics
/
liver disease
/
traditional Chinese medicine
/
traditional Chinese medicine treatment methods
/
metabolic pathways
/
action targets
ZHANG Zheng, TANG Aicun, WEN Zishuai, XIAO Rui, WEI Yanan, FU Lei, MA Bingbing, ZHANG Chenrui, YAO Chun, WU Fangfang.
Application progress of lipidomics in study of traditional Chinese medicine for liver disease treatment[J].
Chinese Traditional and Herbal Drugs,
2026
, 57
(3)
: 1138
-1148
.
DOI: 10.7501/j.issn.0253-2670.2026.03.029
王芷婧, 杨长青. 脂质组学在药物性肝损伤中的应用 [J]. 中华内科杂志, 2021, 60(3): 274-278. 胡聪, 吴琳静, 熊印华, 等. 脂质组学在肝脏疾病中的研究进展 [J]. 中国药理学通报, 2021, 37(1): 6-12. Singh M. Lipidomics study in liver metabolic diseases [D]. Leiden: Leiden University, 2024. Lísa M, Holčapek M. High-throughput and comprehensive lipidomic analysis using ultrahigh-performance supercritical fluid chromatography-mass spectrometry [J]. Anal Chem, 2015, 87(14): 7187-7195. Holčapek M, Liebisch G, Ekroos K. Lipidomic analysis [J]. Anal Chem, 2018, 90(7): 4249-4257. Witting M. Novel Analytical and data analytical approaches for caenorhabditis elegans metabolomics and lipidomics [D]. Freising: Technische Universität München, 2023. Han X L, Gross R W. The foundations and development of lipidomics [J]. J Lipid Res, 2022, 63(2): 100164. Fahy E, Subramaniam S, Brown H A, et al. A comprehensive classification system for lipids [J]. Eur J Lipid Sci Technol, 2005, 107(5): 337-364. Zhang H, Sham T T, Li C, et al. Polygoni Cuspidati Rhizoma et Radix extract attenuates high-fat diet-induced NAFLD in rats: Impact on untargeted serum metabolomics and liver lipidomics [J]. Pharmacol Res Mod Chin Med, 2023, 9: 100335. 詹汉英, 刘瑞林, 王德金, 等. 微波-超声波协同一步提取衍生化-气相色谱-质谱联用快速分析中药材猫爪草中的脂肪酸 [J]. 色谱, 2013, 31(3): 240-248. 金天姿, 罗子宸, 许伟辰, 等. 基于脂质组学探究健脾利湿方对NAFLD小鼠肝脏脂质的调控作用 [J]. 南京中医药大学学报, 2023, 39(5): 420-432. Bang G, Kim Y H, Yoon J, et al. On-chip lipid extraction using superabsorbent polymers for mass spectrometry [J]. Anal Chem, 2017, 89(24): 13365-13373. Merciai F, Basilicata M G, La Gioia D, et al. Sub-5-Min RP-UHPLC-TIMS for high-throughput untargeted lipidomics and its application to multiple matrices [J]. Anal Bioanal Chem, 2024, 416(4): 959-970. Caponigro V, Tornesello A L, Merciai F, et al. Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients [J]. J Transl Med, 2023, 21(1): 918. Hussein N S, S Helmy A, Sherif N M, et al. Lipidomic analysis reveals the efficiency of Eclipta prostrata on diet-induced nonalcoholic fatty liver disease in rats [J]. J Pharm Biomed Anal, 2019, 165: 224-232. Gruber L, Schmidt S, Enzlein T, et al. Deep MALDI-MS spatial omics guided by quantum cascade laser mid-infrared imaging microscopy [J]. Nat Commun, 2025, 16(1): 4759. Qian Y, Guo X Y, Wang Y F, et al. Mobility-modulated sequential dissociation analysis enables structural lipidomics in mass spectrometry imaging [J]. Angew Chem Int Ed, 2023, 62(52): e202312275. Li Z S, Cheng S M, Lin Q H, et al. Single-cell lipidomics with high structural specificity by mass spectrometry [J]. Nat Commun, 2021, 12(1): 2869. Kontiza A, von Gerichten J, Saunders K D G, et al. Single-cell lipidomics: An automated and accessible microfluidic workflow validated by capillary sampling [J]. Anal Chem, 2024, 96(44): 17594-17601. Wang F, Xu S J, Ye F, et al. Integration of transcriptomics and lipidomics profiling to reveal the therapeutic mechanism underlying Ramulus mori (Sangzhi) alkaloids for the treatment of liver lipid metabolic disturbance in high-fat-diet/streptozotocin-induced diabetic mice [J]. Nutrients, 2023, 15(18): 3914. Chang X X, Wang Z, Zhang J L, et al. Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease [J]. J Transl Med, 2016, 14: 266. 李怡, 康舒羽, 王琪文, 等. 小檗碱改善2型糖尿病合并代谢相关脂肪性肝病的机制研究 [J]. 中国药房, 2025, 36(16): 1975-1980. Li Y Y, Chen Y, Zhao C, et al. Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression [J]. Phytomedicine, 2024, 128: 155532. Zhao L J, Zhao H Y, Wei X L, et al. The lipid homeostasis regulation study of arenobufagin in zebrafish HepG2 xenograft model and HepG2 cells using integrated lipidomics-proteomics approach [J]. J Ethnopharmacol, 2020, 260: 112943. Li X, Ge J D, Li Y J, et al. Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease [J]. Acta Pharm Sin B, 2021, 11(11): 3527-3541. 李德周, 奚瑛斐, 辛鑫, 等. 绞股蓝总苷对非酒精性脂肪性肝病小鼠肝脏脂质代谢物的干预作用 [J]. 新中医, 2023, 55(16): 1-9. 崔瀛方. 基于脂代谢的重楼皂苷抗肿瘤机制研究 [D]. 天津: 天津科技大学, 2024. 吴岩斌. 金线莲多糖抗化学性肝损伤及其作用机制的研究 [D]. 福州: 福建农林大学, 2024. 荆柏彤. 基于多组学整合分析桑葚多糖MFP-1抗酒精性肝损伤作用机制研究 [D]. 贵阳: 贵州师范大学, 2025. Chen H G, Peng L, Zhao C, et al. Protective mechanism of Polygonumperfoliatum L. extract on chronic alcoholic liver injury based on UHPLC-QExactive plus mass spectrometry lipidomics and MALDI-TOF/TOF mass spectrometry imaging [J]. Foods, 2022, 11(11): 1583. Song Q, Liu H, Zhang Y Q, et al. Lipidomics revealed alteration of the sphingolipid metabolism in the liver of nonalcoholic steatohepatitis mice treated with scoparone [J]. ACS Omega, 2022, 7(16): 14121-14127. Yang R X, Pan Q, Liu X L, et al. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis [J]. Lipids Health Dis, 2019, 18(1): 179. 许源慧, 亓照耀, 刘金存, 等. 肉苁蓉苯乙醇苷对酒精性肝病模型小鼠脂质代谢稳态的改善作用及其机制 [J]. 中国新药杂志, 2024, 33(7): 696-704. Hu S R, Liang X F, Qin Y M, et al. Alnustone ameliorates metabolic dysfunction-associated steatotic liver disease by facilitating mitochondrial fatty acid β-oxidation via targeting calmodulin [J]. Adv Sci, 2025, 12(31): e11984. Li Y, He X L, Zhou L P, et al. Asiatic acid alleviates liver fibrosis via multiple signaling pathways based on integrated network pharmacology and lipidomics [J]. Eur J Pharmacol, 2022, 931: 175193. Wu X L, Yu Q, Hou Y Z, et al. Emodin-8-O-β-D-glucopyranoside alleviates cholestasis by maintaining intestinal homeostasis and regulating lipids and bile acids metabolism in mice [J]. J Pharm Biomed Anal, 2025, 258: 116734. Wang Y Y, Lu S J, Gui R, et al. Hepatic lipidomics and proteomics analysis reveals the mechanism of Cyclocarya paliurus flavonoids in preventing non-alcoholic steatohepatitis in mice [J]. J Funct Foods, 2022, 99: 105341. 孟瑞媛, 卯明彩, 宋晓, 等. 姜黄素对黄曲霉毒素B1诱导的斑马鱼肝损伤的修复作用 [J]. 农产品质量与安全, 2023(2): 33-39. 苏芮, 裴海鸾, 田骄, 等. 基于网络药理学及实验验证探究二月兰籽水提物对非酒精性脂肪性肝炎大鼠的治疗作用和机制 [J]. 天然产物研究与开发, 2025, 37(2): 346-360. Peng L, Chen H G, Zhou X. Lipidomic investigation of the protective effects of Polygonum perfoliatum against chemical liver injury in mice [J]. J Integr Med, 2023, 21(3): 289-301. Bian L, Chen H G, Zhou X. Untargeted lipidomics analysis of Mori Fructus polysaccharide on acute alcoholic liver injury in mice using ultra performance liquid chromatography-quadrupole-orbitrap-high resolution mass spectrometry [J]. Int Immunopharmacol, 2021, 97: 107521. 刘晓霞. 基于多组学技术的猫屎瓜籽油预防酒精性肠肝损伤及脂质代谢紊乱的分子机制研究 [D]. 西安: 陕西师范大学, 2020. Pérez-Ramírez I F, Gallegos-Corona M A, González-Dávalos M L, et al. Mechanisms associated with the effect of Hypericum perforatum and Smilax cordifolia aqueous extracts on hepatic steatosis in obese rats: A lipidomic approach [J]. Eur J Lipid Sci Technol, 2019, 121(2): 1800403. Wang W Y, Qin J X, Bai S D, et al. Integrative transcriptomics and lipidomics unravels the amelioration effects of RadixBupleuri on non-alcoholic fatty liver disease [J]. J Ethnopharmacol, 2025, 338(Pt 1): 119005. Zhang B Y, Han C R, Zhang Z R, et al. Integrated lipidomic and transcriptomics to explore the effects of ethyl acetate extract of Herpetospermum pedunculosum on nonalcoholic fatty liver disease in mice [J]. J Ethnopharmacol, 2025, 337(Pt2): 118894. Zhang L, Ding X, Su X M, et al. Integrated lipidomics and network pharmacology to reveal the mechanisms of Swertia mussotii franch in the treatment of liver fibrosis in mice [J]. ACS Omega, 2025, 10(25): 26765-26775. 洪菲惠, 陈洁欣, 陈雨婵, 等. 基于非酒精性脂肪性肝炎模型及主成分分析的柴胡拆分组分引经药性归属探讨 [J]. 中国实验方剂学杂志, 2022, 28(15): 53-60. 黄菊. 基于脂质组学探讨鳖甲煎丸治疗非酒精性脂肪性肝炎的药效作用 [D]. 武汉: 中南民族大学, 2024. Li W W, Zhu J, Zhou T, et al. Exploring the mechanisms of Yinchenhao Decoction against ANIT-induced cholestatic liver injury by lipidomics, metabolomics and network pharmacology [J]. J Pharm Biomed Anal, 2025, 258: 116736. 丁珊珊, 廖颖, 李灿东, 等. 基于脂质组学探讨二陈汤对高脂饮食小鼠肝线粒体功能的调节作用 [J]. 中华中医药杂志, 2022, 37(5): 2531-2535. Zhou Y P, Dai Z, Deng K L, et al. Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics [J]. J Pharm Anal, 2023, 13(9): 1058-1069. 张陈芳, 刘凯, 范超文, 等. 温脾丸对不同饮食诱导的非酒精性脂肪性肝病小鼠脂质代谢的影响 [J]. 中国中药杂志, 2025, 50(10): 2730-2739. Shi H L, Chen Q L, Zhang X Y, et al. Efficacy and serum metabolomic analysis of Jiu Wei Qingzhi Formula in treating non-alcoholic fatty liver disease: Study protocol for a parallel-armed, randomized controlled trial [J]. Naunyn Schmiedebergs Arch Pharmacol, 2025. doi: 10.1007/s00210-025-04600-2. 周连丽. 基于“线粒体-脂质代谢网络”研究黄精丸干预代谢相关脂肪性肝病作用机制 [D]. 昆明: 云南中医药大学, 2024. Deng Y J, Pan M X, Nie H, et al. Lipidomic analysis of the protective effects of Shenling Baizhu San on non-alcoholic fatty liver disease in rats [J]. Molecules, 2019, 24(21): 3943. 凡思敏. 芪葛汤激活SIRT6-PPARα信号通路调控肝脏脂肪酸氧化改善NAFLD的机制研究 [D]. 广州: 广州中医药大学, 2023. 祝艳, 章玉玲. 清脂调肝丸对小鼠非酒精性脂肪性肝病代谢的影响研究 [J]. 中医临床研究, 2021, 13(27): 129-130.
PDF下载
全屏
33
11
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
